Dyne Therapeutics
Clinical trials sponsored by Dyne Therapeutics, explained in plain language.
-
New drug trial aims to ease muscle symptoms in myotonic dystrophy
Disease control Recruiting nowThis study tests a new medicine, DYNE-101, in 150 adults with myotonic dystrophy type 1, a condition that causes muscle weakness and stiffness. Participants will receive either the drug or a placebo for 48 weeks to see if it improves muscle function and daily activities. The goal…
Phase: PHASE3 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 17, 2026 05:19 UTC
-
New drug DYNE-101 aims to ease muscle stiffness in rare disease
Disease control Recruiting nowThis study tests a new medicine called DYNE-101 for people with myotonic dystrophy type 1, a condition that causes muscle weakness and stiffness. The trial will check if the drug is safe and helps reduce muscle symptoms. About 116 adults will receive either DYNE-101 or a placebo …
Phase: PHASE1, PHASE2 • Sponsor: Dyne Therapeutics • Aim: Disease control
Last updated May 08, 2026 12:03 UTC